Passage Bio (PASG)10% owner bought ~$2.3K

~$2.3K

Approx. value · 325 sh @ $6.96

592K

Holds after · shares reported

Traded

Sep 11, 2025

Filed

Sep 16, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 22, 2025Insider10% owner purchased ~$71K of PASG shares in the open market
2. Jul 23, 2025Insider10% owner purchased ~$283K of PASG shares in the open market
3. Jul 24, 2025Insider10% owner purchased ~$379K of PASG shares in the open market
4. Sep 11, 2025 · this disclosureInsider · 5 days before an 8-K10% owner purchased ~$2.3K of PASG shares in the open market

What came next

1. Sep 12, 2025Insider · 4 days before an 8-K10% owner purchased ~$138K of PASG shares in the open market
2. Sep 15, 2025Insider · 1 day before an 8-K10% owner purchased ~$83K of PASG shares in the open market
3. Sep 16, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 16, 2025, Saqib Islam notified Passage Bio, Inc. (the “ Company ”) of his decision to resign from the Company’s Board of Directors (the “ Board ”), including from the Audit Committee of the Board (the “ Audit Committee ”), effective immediately (the “ Resignation Date ”).”
4. Nov 10, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Passage Bio

OQRO holds no insider, Congress, fund or contract record for Passage Bio dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PASG page.

Other recent filings by Lynx1 Capital Management LP, 10% owner

• SEC Form 4 at Passage Bio (PASG)Jun 30, 2026
• SEC Form 4 at Tscan Therapeutics (TCRX)Dec 23, 2025
• SEC Form 4 at Tscan Therapeutics (TCRX)Dec 23, 2025
• SEC Form 4 at Tscan Therapeutics (TCRX)Dec 23, 2025
• SEC Form 4 at Neuphoria Therapeutics (NEUP)Oct 24, 2025

The full history of Lynx1 Capital Management LP, 10% owner is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Passage Bio

• SEC Form 4Jun 30, 2026
• SEC Form 4Jan 13, 2026
• SEC Form 4Jan 13, 2026
• SEC Form 4Sep 16, 2025
• SEC Form 4Sep 16, 2025
• SEC Form 4Jul 24, 2025

Everything OQRO holds on this company is on its PASG page.